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Abstract Structural magnetic resonance imaging (MRI)
studies reveal evidence for brain abnormalities in obses-
sive–compulsive disorder (OCD), for instance, reduction of
gray matter volume in the prefrontal cortex. Disturbances
of gyriﬁcation in the prefrontal cortex have been described
several times in schizophrenia pointing to a neurodevel-
opmental etiology, while gyriﬁcation has not been studied
so far in OCD patients. In 26 OCD patients and 38 healthy
control subjects MR-imaging was performed. Prefrontal
cortical folding (gyriﬁcation) was measured bilaterally by
an automated version of the automated-gyriﬁcation index
(A-GI), a ratio reﬂecting the extent of folding, from the
slice containing the inner genu of the corpus callosum up to
the frontal pole. Analysis of covariance (ANCOVA, inde-
pendent factor diagnosis, covariates age, duration of edu-
cation) demonstrated that compared with control subjects,
patients with OCD displayed a signiﬁcantly reduced A-GI
in the left hemisphere (p = 0.021) and a trend for a
decreased A-GI in the right hemisphere (p = 0.076).
Signiﬁcant correlations between prefrontal lobe volume
and A-GI were only observed in controls, but not in OCD
patients. In conclusion, prefrontal hypogyriﬁcation in OCD
patients may be a structural correlate of the impairment in
executive function of this patient group and may point to a
neurodevelopmental origin of this disease.
Keywords Obsessive–compulsive disorder (OCD) 
Magnetic resonance imaging (MRI)  Gyriﬁcation 
Cortical folding  Hypogyria
Introduction
About 1–3% of the worlds’ population suffer from obses-
sive–compulsive disorder (OCD) [4, 20], which causes a
high individual and socioeconomic burden [21]. Clinically,
OCD is characterized by intrusive unwanted thoughts,
ideas, or images that are distressing (obsessions) and urges
to perform ritualistic behaviors or mental acts (compul-
sions) to reduce this distress. Although symptoms tend to
wax and wane through the course of the disorder, OCD
symptoms rarely remit spontaneously.
Brain imaging techniques suggest that speciﬁc neuronal
circuits are responsible for the onset and mediation of OCD
symptoms [38]. Several structural magnetic resonance
imaging (MRI) studies revealed evidence for the presence
of brain abnormalities in OCD, mainly observing reduced
volumes in prefrontal, cingulate, thalamic, and temporo-
limbic regions [e.g. 30, 40]. In a meta-analysis of brain
volume changes in obsessive–compulsive disorder no
volumetric differences were found for the whole brain,
intracranial region, gray matter, or prefrontal cortex, but
OCD patients did show a reduced volume of the left
anterior cingulate cortex and the left and right orbitofrontal
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DOI 10.1007/s00406-009-0096-zcortex compared with control subjects [34]. Functional
imaging studies reported metabolic and functional abnor-
malities in nearly the same brain regions, predominantly
involving not only the orbitofrontal and anterior cingulate
cortices, basal ganglia, and thalamus [e.g. 24, 26, 39, 41],
but also lateral prefrontal cortices [16]. With regard to
these ﬁndings, a dysfunction of particularly prefrontal–
striatal–thalamic-circuitry has been implicated in the
pathophysiology of OCD [41].
In schizophrenia as well as in OCD, changes in shape
complexity measured by fractal dimension of cerebral cor-
tical surface were observed when comparing to healthy
individuals [12]. Both conditions are associated with an
increased heritability, and both disorders are assumed of at
least in part neurodevelopmental origin [33, 45]. Distur-
bances of cortical folding are thought to be related to
abnormalcerebraldevelopment,particularlytoanomaliesof
cortico-cortical [42] and possibly subcortico-cortical con-
nectivity [31]. Cortical folding of the human brain can be
determinedusingthegyriﬁcationindex(GI),whichisaratio
of the inner and the outer contours of the brain [48]. The GI
increases proportionally to the number of gyri [13]. During
prenatal brain development the GI increases approximately
up to the age of one, declines to a stable adult value, and
seems to be independent of age-associated atrophy [2].
In schizophrenia, abnormalities of cortical folding
compared with healthy controls, especially of frontal and
temporal regions, have been demonstrated in several
studies through MR imaging and post mortem [13, 43, 44].
In a family study, frontal hypergyriﬁcation was conﬁrmed
in family members suffering from schizophrenia and in
unaffected ﬁrst-degree relatives compared with healthy
control subjects [8] and in high-risk individuals for the
development of schizophrenia increased right prefrontal
lobe GI served as a predictor for the subsequent progres-
sion into schizophrenic disease [14].
While there is enough evidence for disturbed function
and abnormal structure, especially of prefrontal cortex in
OCD, to our knowledge, no studies were carried out to
examine cortical folding as a potential biological marker
for the latter disease. In the present study, we used an
automated, well-validated method for determining the
automated-gyriﬁcation index (A-GI) for the comparison of
prefrontal cortical folding in OCD patients versus healthy
control subjects [27].
Methods
Subjects
Participants of the study were recruited from the
Department of Psychiatry and Psychotherapy, Saarland
University, between 2003 and 2007. Diagnostically, the
sample consisted of 26 patients with OCD (DSM-IV cri-
teria) and 38 healthy control subjects. Subjects suffering
from dementia, neurological illnesses, severe brain injuries,
or brain tumors at the time of examination were excluded
from the sample. Subjects having a ﬁrst-degree relative
with schizophrenia spectrum disorder were also excluded.
Demographic details by diagnostic group are given in
Table 1.
After a complete description of the study, written
informed consent was obtained from each patient. The
local ethics committees approved the protocol, which is in
accordance with the Declaration of Helsinki.
Diagnostic procedure
The following standardized examinations were performed
on each subject: a detailed biographic interview and a
consensus diagnosis based on SCID I and II interviews of
two independent psychiatrists. The status of healthy con-
trols was conﬁrmed using SCID I and II. For the OCD
patients, duration of illness, age of onset, depressive
symptoms with the beck depression inventory (BDI) [5],
and severity of OCD symptoms using the Yale-Brown
Obsessive Compulsive Scale (Y-BOCS) [10] were
assessed.
Neuropsychological assessment
To assess cognitive performance of frontal lobe function,
we applied a small test battery focusing on executive
function. For the detection of deﬁcits in concept formation,
cognitive ﬂexibility, and executive functions, the Wisconsin
Card Sorting Test (WCST [15]), and the Tower of London
test (TOL; [37]) were used. Additionally, a test tapping the
controlled integration of information from different sensory
channels, that is, intermodal comparison (IC, ‘‘Intermodaler
Vergleich’’, subtest of the Attention Test Battery, TAP,
Zimmermann, Fimm/PSYTEST) was conducted. For
assessment of psychomotor performance and speed, we
used the ‘‘Zahlenverbindungstest’’ (ZVT; [28]), a test
similar to the trail-making test (TMT, part A).
MRI acquisition
MRI scanning was performed on a 1.5 T Siemens-Mag-
netom using a T1-weighted MPRAGE sequence with 176
consecutive slices of 1 mm thickness and a pixel size of
1 9 1m m
2. Prior to analysis, scans were realigned so that
the coronal plane was orthogonal to the AC–PC line.
Details on image preprocessing operations were descri-
bed in previous work [27]. Brieﬂy summarized, the SPM
package (http://www.ﬁl.ion.ucl.ac.uk/spm/)[ 3] was used to
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123perform preprocessing functions on images used in this
study. The T1 candidate scans were segmented in native
space using the SPM segment function, after which the
SPM brain extraction function recovered a tissue mask for
each scan. These masks were combined with the native T1s
to give each brain a T1 tissue image with nonbrain tissue
and CSF removed. The SPM coregistration function pro-
vided a mapping of the extracted brains into the Montreal
Neurological Institute (MNI) space to obtain AC–PC reg-
istration while maintaining the native space volumes. This
mapping into the MNI space without size or shape
adjustment was applied to the original T1, the brain tissue
mask, and the three native space segments. These AC–PC
registered images were then resliced to 1 9 1 9 1c m
2
voxel size, and they formed the base data structure, upon
which automated-gyriﬁcation index (A-GI) was imple-
mented. Volumes of total gray matter (GM), total white
matter (WM), and cerebrospinal ﬂuid (CSF) were obtained
as per SPM voxel-based morphometry (VBM) protocols
using a MATLAB algorithm [3]. Volumes of the prefrontal
lobes were obtained using an automated parcellation pro-
cedure implemented in the A-GI software [6, 32], and
relative prefrontal volumes were calculated by dividing the
absolute prefrontal lobe volumes through whole brain
volume (sum of GM, WM and CSF).
Automated-gyriﬁcation index (A-GI) processing
A full description of the A-GI process was given elsewhere
[6, 27]. Brieﬂy, the process can be divided into two pro-
cedures, the prefrontal lobe detection and the A-GI
extraction. In the ﬁrst procedure, an automated parcellation
procedure is used to locate the left and right prefrontal
lobes. In the second automated procedure, the inner and
outer contours are traced. In A-GI, the inner trace is a
composite of the exposed surface and closed sulci tracings.
The outer contour overlaps the inner contour exposed
surface traces, except where open sulci occur near the
cortical surface. Once the outer and inner contours have
been traced, the GI values are calculated for each slice and
exported to a tab-delimited text ﬁle format. Measurements
were taken on every 1 mm prefrontal slice, approximating
40 slices per brain. The GI values for each slice within the
region were summed and then divided by the number of
slices, producing a mean GI value for each individual. In
Fig. 1a and b, the outer and inner A-GI contour of one
prefrontal slice is illustrated.
Statistical analysis
The A-GI tool is deterministic and its repeated application
to the same scan will generate an intraclass correlation
co-efﬁcient (ICC) value of 1.00. In a same-subject rescan
repeatability test, it was demonstrated that the A-GI tool
obtained an ICC of 0.99, reﬂecting a low susceptibility to
scanner noise [27]. Equivalent discriminatory power and
repeated ﬁndings were also demonstrated in the compari-
son between manual and A-GI [27].
All statistical testing was conducted with SPSS for
Windows 14 (SPSS Inc., Chicago, IL, USA). All tests were
two-tailed. The level of signiﬁcance was set at a = 0.05.
Dependent variables were right and left A-GI, and
their asymmetry coefﬁcient (2 9 (A-GIright - A-GIleft)/
(A-GIright ? A-GIleft)), and in an additional analysis rela-
tive prefrontal lobe volume. Independent variable was
diagnosis (OCD patients, healthy controls). For dependent
variables, the normality assumption was inspected with the
Kolmogorov–Smirnov test.
Fig. 1 a Automated GI—inner contour legend: A-GI total inner
contour trace on a coronal slice of a control subject. Colors: blue
exposed inner contour right; green exposed inner contour left: yellow
buried inners. A-GI automated gyriﬁcation index. b Automated GI—
outer contour legend: A-GI total outer contour trace on a coronal slice
of a control subject; inner contours overlaid with smoothed outer and
IFH trace in red. A-GI automated gyriﬁcation index; IFH interhemi-
sphere ﬁssure
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123Oneway analysis of variance (ANOVA) was performed
to analyze if there were signiﬁcant age or education dif-
ferences between the two diagnostic groups. Chi-square
test on independence was used to analyze if the distribution
of gender and hand preference was different between the
groups. Pearsons product–moment-correlations between
dependent variables and age as well as duration of educa-
tion were calculated for both diagnostic groups. For the
control sample, dependent variables were inspected on
gender and hand preference differences with oneway
ANOVA.
These preliminary statistics determined the main anal-
ysis. Since age and education correlated signiﬁcantly with
A-GI values, analysis of covariance (ANCOVA) with
independent factor diagnosis and covariates age and dura-
tion of education was performed.
To investigate the inﬂuence of clinical variables, partial
correlations adjusted for age and duration of education
between A-GI and duration of illness, age of onset of the
disease, Y-BOCS, and BDI were computed. To determine
the inﬂuence of brain volume on A-GI, partial correlations
(PC) adjusted for age between relative prefrontal lobe
volume and corresponding A-GI were calculated.
Results
Sociodemographic, clinical, and neurocognitive
parameters
The patients suffering from OCD were signiﬁcantly less
educated than the healthy control subjects; there were no
signiﬁcant differences between the groups with regard to
gender, age, and handedness. The cognitive performance of
OCD patients compared with control subjects focussing on
executive functions was signiﬁcantly reduced in the WCST
(persverative reponses; p = 0.018) and TOL (total score;
p = 0.019). In addition, OCD patients showed a prolonged
reaction time in the intermodal comparison subtest of the
TAP at a trend level. Detailed sociodemographic, clinical,
and neuropsychological data as well as GI measurements
of prefrontal lobe are presented in Table 1.
Gyriﬁcation index (GI)
For all dependent variables there were no signiﬁcant
deviations from the normality assumption. There was a
signiﬁcant negative correlation between age and A-GI on
both sides and in both diagnostic groups (p\0.05) (for
details see Fig. 2). In addition, left and right A-GI were
signiﬁcantly positive correlated with duration of education
in the total group of subjects (r = 0.34, p = 0.01 for right
A-GI and r = 0.36, p\0.001 for left A-GI) and in the
subgroup of control subjects (r = 0.36, p = 0.03; both
sides), but not in OCD patients.
Analysis of covariance (ANCOVA; factor diagnosis,
intervening variables age and duration of education) dem-
onstrated that compared with control subjects, patients with
OCD displayed a signiﬁcantly reduced A-GI on the left
side (df = 1, 58; F = 5.65; p = 0.021) and a trend for a
decreased A-GI on the right side (df = 1, 58; F = 3.26;
p = 0.076). No signiﬁcant difference was found with
regard to the asymmetry coefﬁcient of the GI (for details
see Table 2).
There were no signiﬁcant differences in GI between
males and females in our study sample. However, to rule
out a signiﬁcant inﬂuence of gender on dependent vari-
ables, we calculated an additional ANOVA (diagnostic
group 9 gender) showing no signiﬁcant effect of gender.
There were no signiﬁcant correlations between A-GI
values and duration of illness, age of onset of the disease,
Y-BOCS (total score), or BDI (total score). In addition, we
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Fig. 2 Relationship between prefrontal GI and age legend: correlation between left and right prefrontal GI and age. GI gyriﬁcation index
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123calculated the partial correlations between the obsession
and compulsion subscore of the Y-BOCS and the GI (left
and right). We found no signiﬁcant relationship (p[0.2).
To take a closer look onto a possible correlation between
severity of OCD and GI, we analysed if there is a differ-
ence in GI between OCD patients displaying only moderate
obsessions–compulsions and OCD patients with severe
symptoms (based on Y-BOCS rating). We found no sig-
niﬁcant differences between the subgroups (for left GI
p = 0.98; for right GI p = 0.53). Nevertheless, building
these two subgroups, we observed a signiﬁcant difference
in left GI only when comparing OCD patients with severe
symptoms (n = 9) with controls (GI reduction 3.5%;
F = 3.02, df = 2, 51; p = 0.036, ANCOVA), not when
comparing OCD patients displaying only moderate symp-
toms (n = 11) with healthy controls.
Across groups we found no signiﬁcant correlations
between test performance and A-GI. However, in the
subgroup of OCD patients we observed a signiﬁcant cor-
relation between the TOL total score and right GI
(q = 0.61, p = 0.046). This partial correlation did not
survive correction for multiple testing.
Prefrontal lobe volumes
There was only a slight reduction at a trend level in left
relative prefrontal lobe in OCD patients compared with
healthy control subjects, but no signiﬁcant differences in
relative prefrontal lobe volumes between the diagnostic
groups (left: df = 1, 61, F = 2.89, p = 0.094; right:
df = 1, 61, F = 2.89, p = 0.26) (see Table 2).
Clinical variables (age of onset, duration of illness, BDI,
Y-BOCS) did not show a signiﬁcant correlation with pre-
frontal lobe volume in OCD patients. However, we could
demonstrate a signiﬁcant positive correlation between
prefrontal A-GI and corresponding relative prefrontal lobe
volume in healthy controls (right: PC = 0.41; df = 35;
p = 0.01; left: PC = 0.40; df = 35; p\0.005), but not in
OCD patients (right: PC = 0.17; p = n.s.; left: PC = 0.30;
p = n.s.).
Inﬂuence of medication
Exact medication records were available for 20 OCD
patients: eight receiving SSRIs, three receiving tricyclic
antidepressants (TCA), and nine patients receiving no
antidepressants. To rule out the inﬂuence of medication, we
repeated our analysis including only the nine medication-
naı ¨ve OCD patients. We found that this subgroup of
unmedicated OCD patients displayed signiﬁcant reduced
prefrontal GI on both hemispheres compared with control
subjects (GI right 3.7% reduction in OCD patients; 2.113
vs. 2.195; p = 0.003 and GI left 3.4% reduction in OCD
patients; 2.056 vs. 2.129; p = .004). This underlines that
medication could not be responsible for the GI difference
between OCD patients and control subjects.
Discussion
In our study, OCD patients demonstrated signiﬁcant left-
sided hypogyriﬁcation and at a trend level right-sided
reduced gyriﬁcation of prefrontal lobe compared with
healthy control subjects. This difference occurred in the
absence of signiﬁcant prefrontal lobe volume differences.
Interestingly, we found a signiﬁcant correlation between
relative prefrontal lobe volumes and gyriﬁcation (A-GI) in
control subjects, but not in OCD patients. This may reﬂect
that reduced cortical folding in the prefrontal lobe serves as
an independent biological vulnerability marker for OCD.
A not-signiﬁcant association between volume and folding
in OCD patients could strongly point towards disturbed
neurodevelopment or brain maturation in OCD patients.
Volumetric and functional abnormalities of prefrontal and
temporo-limbic cortical regions in OCD were found in
several imaging studies, but this is the ﬁrst study to report
on gyriﬁcation and cortical folding in OCD patients. In so
far these results have to be replicated in further investiga-
tions with different samples to prove this ﬁnding as a stable
marker of disturbances in late neurodevelopment in OCD
patients. Interestingly, a recent volumetric MRI study
showed that thalamic volumes were signiﬁcantly nega-
tively correlated with orbitofrontal cortex (OFC) volumes
in OCD patients, but not in healthy subjects [35]. The
authors suggested with additional support of a meta anal-
ysis that structural alterations of both the thalamus and the
OFC are inversely and speciﬁcally related in OCD. This ﬁts
Table 2 Gyriﬁcation and prefrontal lobe volume in OCD versus
control subjects
Age Education Diagnosis
pp F d f p
GI right
a \0.0005 0.23 3.3 1, 58 0.076
GI left
a \0.0005 0.20 5.7 1, 58 0.021
GI asymmetry coefﬁcient
b – – 0.3 1, 51 0.58
Right relative PFL volume
c 0.002 – 1.28 1, 61 0.26
Left relative PFL volume
c 0.005 – 2.89 1, 61 0.094
GI gyriﬁcation index, OCD obsessive–compulsive disorder, PFL
prefrontal lobe, FF -statistic, df degrees of freedom, p probability
a Analysis of covariance (ANCOVA; factor diagnosis, intervening
variables: age, duration of education)
b Only right-handed subjects; analysis of variance (ANOVA; diag-
nosis, no intervening variables)
c Analysis of covariance (ANCOVA; factor diagnosis, intervening
variable: age)
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123to the results of our study that not only volume alterations
of one brain area but also the relationship between con-
necting brain regions (e.g. thalamus and OFC) or mis-
matches between structural parameters (e.g. prefrontal lobe
volume and GI) may contribute to the neurobiological
vulnerability for OCD.
While the meaning of GI is not completely under-
stood, it seems to be obvious that cortical folding serves
as a marker of late ontogenetic brain development.
Axonal tracts begin to develop before the onset of cor-
tical folding [32] and lesions of tracts effect different
gyral patterns [31] suggesting the importance of axonal
connectivity to cortical folding. This assumption is in
line with the tension-based theory of morphogenesis [42].
According to this model, differences in mechanical ten-
sion along axons connecting different cortical regions
effect cortical folding. The gyriﬁcation pattern speciﬁc to
humans is largely complete by birth and displays smooth
and continuous development. Gyri and sulci appear in a
speciﬁc order: the least variable ‘‘primary’’ gyri are ﬁrst
to appear, followed by the moderately variable ‘‘sec-
ondary’’ gyri, and then ﬁnally, the most variable ‘‘ter-
tiary’’ gyri develop [2]. In humans, the sulco-gyral
development continues until early adulthood. Although
maximal GI values are reached in infancy, a process of
‘‘compensation’’ allows for continued growth to be
accommodated by compensatory tertiary folding which
maintains GI levels [2].
However, focal hypo- or hyper-gyria can be a conse-
quence of disturbed fetal blood supply, intrauterine infec-
tion, or prenatal toxic events in human subjects as well.
Animal experiments have demonstrated wide ranging
misconnections in the neighborhood of focal disturbances
of gyriﬁcation [9]. Disturbed gyriﬁcation, as now detected
in OCD and as previously described in schizophrenia,
seems to be associated with an abnormal development of
cortical connectivity.
Structural MRI investigations revealed evidence for a
reduction of orbitofrontal volume in OCD patients com-
pared with healthy controls, strongly indicating the
involvement of the prefrontal cortex in the pathogenesis
of OCD [19]. In our study, OCD patients demonstrated
tendentially but not signiﬁcantly smaller relative pre-
frontal lobe volumes on the left side compared with
healthy controls; nevertheless, prefrontal A-GI differed
signiﬁcantly on the left side and at a trend level on the
right side. Interestingly, we found a signiﬁcant correlation
between relative prefrontal lobe volumes and A-GI only
in control subjects, but not in OCD patients. This implies
the possible implications discussed earlier. It could mean
that reduced cortical folding in the prefrontal lobe is a
biological vulnerability marker independent from reduced
prefrontal lobe volume in OCD patients. Alternatively or
additionally, the not-signiﬁcant association of volume and
folding in OCD patients could support strongly the
hypothesis of a disturbed neurodevelopment or brain
maturation in OCD.
Functional imaging studies [23] demonstrate abnor-
malities of glucose metabolism in the prefrontal cortex in
OCD patients, which normalize after the successful treat-
ment of symptoms [18]. This ﬁnding is another hint of the
clinical relevance of the prefrontal cortex for the patho-
genesis of OCD.
In one recent study, relatives of OCD cases from the
community had a 8.5-fold increase in the prevalence of
deﬁnite OCD, and relatives from OCD cases from outpa-
tient clinics had a 4.9-fold increase in the prevalence of
deﬁnite OCD compared with relatives from control cases
[11]. Older twin studies on OCD found concordance rates
in monozygotic versus dizygotic twins of 80 versus 20%
[17] and 87 versus 47% [7], altogether suggesting that there
is a high genetic vulnerability. A family study investigating
GI in affected and unaffected ﬁrst degree relatives of
schizophrenia patients showed focal hypergyriﬁcation also
in unaffected family members supporting a genetic liability
of GI [8].
Our ﬁndings of a signiﬁcant negative correlation
between prefrontal GI and age differ from the results of
other investigations showing that the GI is age-independent
[2], especially when we found the correlation in both, OCD
patients and healthy control subjects. It has been previously
reported that GI is a stable measure, ﬁxed in early devel-
opment and therefore relatively independent of age [48]. It
is theoretically possible that medications taken by OCD
patients may have affected these results, but then the effect
of drugs would not be seen in healthy controls, as it could
be demonstrated in our study. In addition, other studies
have also identiﬁed age-related changes in GI [6, 36]. This
suggests that GI may not be as stable a measure as previ-
ously thought to be and raises the possibility that, while the
degree of cortical folding may relate to early develop-
mental factors, GI itself is vulnerable to other factors such
as age-related changes in the shape of gyri and the depth of
sulci [22]. It was reported that sulcal depth reduces with
age, making the curvature at the crown of the gyri more
gradual [25]. These effects give rise to a shortening of the
inner contour and hence lower GI values. In turn, this raises
the possibility that the differences in GI which we report
may result from a process occurring after the early devel-
opmental period. Furthermore, GI did correlate signiﬁ-
cantly with education in the control subjects, a result that
could not be found in previous studies of our research
group. In this sample, we did not repeat the measurement
with A-GI by manual tracing and calculating the manual
measured GI (M-GI) used in the schizophrenia studies, but
we compared both methods in a sample of twins. We found
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with the M-GI (A-GI is lower), the observed differences
between the diagnostic groups were similar [46].
There is an increased prevalence of comorbid OCD in
patients with schizophrenia, reaching from 0.5 to 59.2%,
and of obsessive–compulsive symptoms (OCS) in
schizophrenia from 3.5 to 46%, depending on the speciﬁc
sample [29]. There is a controversial discussion going on
if this increased prevalence reﬂects a true comorbidity or
a diagnostic subcategory of schizophrenia. There are
some hints that schizophrenic patients with OCS showed
a different extent of volume reductions compared with
schizophrenic patients without OCS. In this subgroup, the
volume reductions were more pronounced in, e.g., left
hippocampus and frontal lobes [1]. In addition, in some
studies schizophrenic patients with OCS demonstrated
more neurological soft signs, motor symptoms including
catatonia, and extrapyramidal symptoms [29]. Until
today, there are no studies available measuring GI in
schizophrenia patients with OCS. Nevertheless, it can be
speculated that these patients may show a more pro-
nounced reduced GI compared with schizophrenia
patients without OCS.
Some limitations of this study should be borne in mind
when interpreting the results. First, although the number
of subjects is still relatively large in comparison to other
imaging studies, the results are still in need of replication.
Second, we did not ﬁnd a correlation of reduced gyriﬁ-
cation in OCD patients to clinical variables; therefore, the
clinical impact of our ﬁnding beyond that of increased
vulnerability for the development of OCD still remains
unclear. Third, we did not assess depressive (BDI) and
OCD (Y-BOCS) symptoms in the healthy control group
for analysing a possible relationship between minor
degree symptomatology and GI in healthy people. At
least, we did not correct for multiple testing, which limits
our results. In our small sample, we focused primarily on
our hypothesis that GI is different between OCD patients
and controls. All other analyses were secondary analyses,
not causally linked to our primary outcome. Adjustment
for multiple testing would lead to nonsigniﬁcant results in
nearly all of our primary and secondary outcome
parameters.
While structural MRI studies revealed evidence for
brain abnormalities in OCD, gyriﬁcation has not been
studied so far in OCD patients. Here, for the ﬁrst time, we
have found evidence of reduced prefrontal gyriﬁcation in
OCD. Our ﬁndings support and extend other studies
reporting structural and functional brain abnormalities of
prefrontal cortex in OCD and provide further evidence that
OCD is associated with neurodevelopmental processes
affecting prefrontal cortex and its associated executive
functions.
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